雷火电竞app

EN
EN
Research platforms
Biomarkers and Translational Research Platform
IHC Platform

Our CAP-certified immunohistochemistry testing platform enables robust biomarker development for both patient stratification and exploratory investigations, offering:
•    Custom IHC assay development and validation services for novel biomarkers
•    Multiplex Immunohistochemistry/Multiplex Immunofluorescence
•    RNAscope™ In Situ Hybridization
CAP Accreditation for InnoStar IHC Testing

Contact Us

For more information, please contact us.

Contact Us
MESSAGE
  • *
  • *
  • *
  • *
  • *
Consultation product molecular type
Message content

Copyright © 2017-2021©Shanghai InnoStar Bio-tech Co., Ltd. All Rights Reserved. Created By VPABrand.com